Literature DB >> 26389558

Progestin therapy in endometriosis.

Altay Gezer1, Engin Oral1.   

Abstract

Progestins are synthetic compounds that mimic the effects of progesteron. For over 50 years, oral progestins have been demonstrated to be effective in the treatment of endometriosis. They were reported to reduce or eliminate pain symptoms in approximately 90% of the patients. Progestins are available in many forms, including oral preparations, injections, subdermal implants and intrauterine systems. Continuous progestin use is an effective therapy for the treatment of painful symptoms associated with endometriosis but there had been no evidence of progestin use being superior to other types of treatment in endometriosis-related pain symptoms.

Entities:  

Keywords:  endometriosis; progesterone; progestin; therapy

Mesh:

Substances:

Year:  2015        PMID: 26389558     DOI: 10.2217/whe.15.42

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN: 1745-5057


  7 in total

1.  Radical surgery for pseudo-ovarian malignancy: a case report of bowel endometriosis with massive ascites.

Authors:  Yiting Bao; Wu Huang; Liangqing Yao; Lei Yuan
Journal:  Gland Surg       Date:  2022-05

2.  An Efficient UPLC-MS/MS Method Established to Detect Relugolix Concentration in Rat Plasma.

Authors:  Liying Xing; Ya-Nan Liu; Hongye Yao; Tingting Wang; Fuchen Xie; Shunbin Luo; Pingping Luo; Shengling Tang
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

3.  Role of SIRT1 and Progesterone Resistance in Normal and Abnormal Endometrium.

Authors:  Tae Hoon Kim; Steven L Young; Tsutomu Sasaki; Jeffrey L Deaton; David P Schammel; Wilder Alberto Palomino; Jae-Wook Jeong; Bruce A Lessey
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 6.134

Review 4.  The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review).

Authors:  Magdalenia Bałkowiec; Radosław B Maksym; Paweł K Włodarski
Journal:  Mol Med Rep       Date:  2018-07-23       Impact factor: 2.952

5.  Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results.

Authors:  Yutaka Osuga; Yoshifumi Seki; Masataka Tanimoto; Takeru Kusumoto; Kentarou Kudou; Naoki Terakawa
Journal:  BMC Womens Health       Date:  2021-06-21       Impact factor: 2.809

6.  Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.

Authors:  Fernando M Reis; Larissa M Coutinho; Silvia Vannuccini; Frédéric Batteux; Charles Chapron; Felice Petraglia
Journal:  Hum Reprod Update       Date:  2020-06-18       Impact factor: 15.610

7.  Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions.

Authors:  Sahar Houshdaran; Joseph C Chen; Júlia Vallvé-Juanico; Shayna Balayan; Kim Chi Vo; Karen Smith-McCune; Ruth M Greenblatt; Juan C Irwin; Linda C Giudice
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.